Cargando…
HMGB1: A Promising Therapeutic Target for Prostate Cancer
High mobility group box 1 (HMGB1) was originally discovered as a chromatin-binding protein several decades ago. It is now increasingly evident that HMGB1 plays a major role in several disease conditions such as atherosclerosis, diabetes, arthritis, sepsis, and cancer. It is intriguing how deregulati...
Autores principales: | Gnanasekar, Munirathinam, Kalyanasundaram, Ramaswamy, Zheng, Guoxing, Chen, Aoshuang, Bosland, Maarten C., Kajdacsy-Balla, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666291/ https://www.ncbi.nlm.nih.gov/pubmed/23766911 http://dx.doi.org/10.1155/2013/157103 |
Ejemplares similares
-
Vitamin K2, a Naturally Occurring Menaquinone, Exerts Therapeutic Effects on Both Hormone-Dependent and Hormone-Independent Prostate Cancer Cells
por: Samykutty, Abhilash, et al.
Publicado: (2013) -
Vitamin K and its analogs: Potential avenues for prostate cancer management
por: Dasari, Subramanyam, et al.
Publicado: (2017) -
Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells
por: Samykutty, Abhilash, et al.
Publicado: (2013) -
Sumoylation of Human Translationally Controlled Tumor Protein Is Important for Its Nuclear Transport
por: Munirathinam, Gnanasekar, et al.
Publicado: (2012) -
MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)